Disposition of two highly permeable drugs in the upper gastrointestinal lumen of healthy adults after a standard high-calorie, high-fat meal
article
OA: closed
CC0
⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the disposition of two highly permeable drugs within the upper gastrointestinal tract of healthy adults following the ingestion of a standard high-calorie, high-fat meal.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Luminal Lipid Phases after Administration of a Triglyceride Solution of Danazol in the Fed State and Their Contribution to the Flux of Danazol Across Caco-2 Cell Monolayers 2012
- In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media 2005
Cited by (1)
References (38)
- In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media via openalex
- Luminal Lipid Phases after Administration of a Triglyceride Solution of Danazol in the Fed State and Their Contribution to the Flux of Danazol Across Caco-2 Cell Monolayers via openalex
- doi:10.1172/jci107226 via openalex
- doi:10.1007/s11095-005-8476-1 via openalex
- doi:10.1208/s12248-019-0380-4 via openalex
- doi:10.1152/ajpgi.1985.249.5.g580 via openalex
- doi:10.1016/0378-5173(83)90018-2 via openalex
- doi:10.1023/a:1011958400362 via openalex
- doi:10.1007/s11095-011-0506-6 via openalex
- W1441769318 via openalex
- doi:10.1016/0016-5085(83)90382-7 via openalex
- doi:10.1002/jps.2600690525 via openalex
- W6674403076 via openalex
- W6771912324 via openalex
- doi:10.1016/0378-5173(84)90091-7 via openalex
- doi:10.1111/j.1365-2982.2006.00759.x via openalex
- doi:10.1016/s0731-7085(03)00246-2 via openalex
- doi:10.1016/s0016-5085(76)80010-8 via openalex
- doi:10.1211/0022357023367 via openalex
- doi:10.1021/mp500022u via openalex
- doi:10.1016/0016-5085(90)91150-5 via openalex
- doi:10.1016/j.ejps.2014.01.009 via openalex
- doi:10.1016/j.ejps.2016.05.013 via openalex
- doi:10.4333/kps.2004.34.3.223 via openalex
- doi:10.1023/a:1026155822121 via openalex
- doi:10.1002/jps.20477 via openalex
- doi:10.1080/00365520600610451 via openalex
- doi:10.1002/jps.2600581117 via openalex
- doi:10.1007/bf02233563 via openalex
- doi:10.1136/gut.16.10.777 via openalex
- doi:10.1021/acs.molpharmaceut.8b00865 via openalex
- doi:10.1093/ajhp/38.9.1400 via openalex
- doi:10.1016/j.ejpb.2008.05.011 via openalex
- doi:10.3390/ijms160612871 via openalex
- doi:10.1016/j.ejps.2015.11.012 via openalex
- doi:10.1016/s0016-5085(82)80140-6 via openalex
- doi:10.7326/0003-4819-94-6-826_2 via openalex
- doi:10.1023/a:1007568900147 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:51:31.497383+00:00
License: CC0
· commercial use OK